C. Stein

Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo

B. Davidson, B. Ross, S. Beer, 1998, Gene Therapy.

Extensive beta-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain.

B. Davidson, C. Stein, C. Stein, 1998, Human gene therapy.

Long‐term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)‐deficient mice by adenovirus‐mediated LDLR gene transfer combined with CD154 blockade

I. Martins, B. Davidson, C. Stein, 2000, The journal of gene medicine.

In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.

I. Martins, B. Davidson, P. McCray, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

I. Martins, R. Kotin, B. Davidson, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus

N. Rooijen, B. Davidson, C. Stein, 1998, Gene Therapy.

Molecular and Biological Aspects of AZT Resistant Viruses Derived from HIV-1 Infected Individuals

J. Oxford, C. Stein, P. Levantis, 1993 .

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

I. Martins, R. Kotin, B. Davidson, 2000, Proceedings of the National Academy of Sciences of the United States of America.